These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22805177)

  • 1. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation.
    Prabowo AS; Anink JJ; Lammens M; Nellist M; van den Ouweland AM; Adle-Biassette H; Sarnat HB; Flores-Sarnat L; Crino PB; Aronica E
    Brain Pathol; 2013 Jan; 23(1):45-59. PubMed ID: 22805177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.
    Way SW; McKenna J; Mietzsch U; Reith RM; Wu HC; Gambello MJ
    Hum Mol Genet; 2009 Apr; 18(7):1252-65. PubMed ID: 19150975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB; Aronica E; Baltuch G; Nathanson KL
    Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
    Boer K; Troost D; Jansen F; Nellist M; van den Ouweland AM; Geurts JJ; Spliet WG; Crino P; Aronica E
    Neuropathology; 2008 Dec; 28(6):577-90. PubMed ID: 18410267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal brain mTOR signaling activation in tuberous sclerosis complex.
    Tsai V; Parker WE; Orlova KA; Baybis M; Chi AW; Berg BD; Birnbaum JF; Estevez J; Okochi K; Sarnat HB; Flores-Sarnat L; Aronica E; Crino PB
    Cereb Cortex; 2014 Feb; 24(2):315-27. PubMed ID: 23081885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subependymal giant cell astrocytoma associated with tuberous sclerosis complex -  pharmacological treatment using mTOR inhibitors].
    Zitterbart K
    Klin Onkol; 2014; 27(6):401-5. PubMed ID: 25493579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.
    Ferrer I; Mohan P; Chen H; Castellsague J; Gómez-Baldó L; Carmona M; García N; Aguilar H; Jiang J; Skowron M; Nellist M; Ampuero I; Russi A; Lázaro C; Maxwell CA; Pujana MA
    J Pathol; 2014 Jul; 233(3):247-57. PubMed ID: 24604753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
    Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
    Hino O; Kobayashi T
    Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
    Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
    Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
    Prato G; Mancardi MM; Baglietto MG; Janis S; Vercellino N; Rossi A; Consales A; Raso A; Garrè ML
    J Child Neurol; 2014 Sep; 29(9):NP54-7. PubMed ID: 24056156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
    Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
    J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
    Malik AR; Liszewska E; Skalecka A; Urbanska M; Iyer AM; Swiech LJ; Perycz M; Parobczak K; Pietruszka P; Zarebska MM; Macias M; Kotulska K; Borkowska J; Grajkowska W; Tyburczy ME; Jozwiak S; Kwiatkowski DJ; Aronica E; Jaworski J
    Acta Neuropathol Commun; 2015 Jul; 3():48. PubMed ID: 26220190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bama miniature pig model of monoallelic TSC1 mutation for human tuberous sclerosis complex.
    Li X; Hu T; Liu J; Fang B; Geng X; Xiong Q; Zhang L; Jin Y; Liu X; Li L; Wang Y; Li R; Bai X; Yang H; Dai Y
    J Genet Genomics; 2020 Dec; 47(12):735-742. PubMed ID: 33612456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.
    Way SW; Rozas NS; Wu HC; McKenna J; Reith RM; Hashmi SS; Dash PK; Gambello MJ
    Hum Mol Genet; 2012 Jul; 21(14):3226-36. PubMed ID: 22532572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus tablets for patients with subependymal giant cell astrocytoma.
    Turner SG; Peters KB; Vredenburgh JJ; Desjardins A; Friedman HS; Reardon DA
    Expert Opin Pharmacother; 2011 Oct; 12(14):2265-9. PubMed ID: 21806479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?
    Chan JY; Wang KH; Fang CL; Chen WY
    PLoS One; 2014; 9(2):e89467. PubMed ID: 24558502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.